🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
VISEN Pharmaceuticals (HKG:2561)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.09
-0.41 (-3.90%)
Nov 20, 2026, 3:48 PM HKT

VISEN Pharmaceuticals Revenue

VISEN Pharmaceuticals had revenue of 34.81M CNY in the half year ending June 30, 2026, with 1,133.16% growth. This brings the company's total for the last twelve months to 34.06M, up 3,950.06% year-over-year. In the year 2025, VISEN Pharmaceuticals had annual revenue of 136.00K, down -95.10%. That makes VISEN Pharmaceuticals the 40,040th largest company in the world by revenue and 2,444th in Hong Kong.

Revenue (ttm)
34.06M CNY
Revenue Growth
+3,950.06%
P/S Ratio
28.04
Revenue / Employee
333.93K CNY
Employees
102
Market Cap
1.10B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025136.00K-2.64M-95.10%
Dec 31, 20242.78M4.45M-
Dec 31, 2023-1.67M629.00K-
Dec 31, 2022-2.30M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

VISEN Pharmaceuticals News

More News